Table 1.
Seroprevalence of T. gondii infection according to the demographic and clinical data of patients with COVID-19 (269) attending the Babol University affiliated Hospital, Babol, Iran
| Variable | No. tested | Seropositivity N (%) | OR (95%CI) | P value |
|---|---|---|---|---|
| Age | ||||
| < 40 | 40 | 30 (75) | ||
| 40–60 | 76 | 61 (80.3) | 0.7 (0.30–1.84) | 0.33* |
| > 60 | 153 | 135 (88.2) | 0.5 (0.27–1.15) | 0.08 |
| Gender | ||||
| Male | 105 | 89 (84.8) | 0.9 (0.47–1.79) | 0.79 |
| Female | 164 | 137 (83.5) | ||
| Hospital wards | ||||
| General | 172 | 142 (82.6) | 0.9 (0.42–1.89) | 0.75 |
| ICU | 70 | 59 (84.3) | ||
| NA | 27 | - | ||
| Respiratory rate | ||||
| < 28 | 150 | 122 (81.3) | 0.6 (0.32–1.24) | 0.18 |
| > 28 | 119 | 104 (87.4) | ||
| O2 saturation | ||||
| < 93 | 147 | 126 (85.7) | ||
| 93–95 | 49 | 39 (79.6) | 1.5 (0.67–3.54) | 0.21* |
| > 95 | 73 | 61 (83.6) | 0.8 (0.30–3.95) | 0.37 |
| Bleeding | ||||
| Yes | 58 | 52 (89.7) | 1.8 (0.77–4.67) | 019 |
| No | 211 | 174 (82.5) | ||
| Trombose | ||||
| Yes | 13 | 10 (76.9) | 0.6 (0.16–2.34) | 0.49 |
| No | 256 | 216 (84.3) | ||
| Cough | ||||
| Yes | 217 | 185 (85.3) | 1.5 (0.22–3.33) | 0.26 |
| No | 52 | 41 (78.8) | ||
| Dyspnea | ||||
| Yes | 150 | 125 (83.3) | 0.9 (0.46–1.72) | 0.73 |
| No | 119 | 101 (84.9) | ||
| Fever | ||||
| Yes | 221 | 187 (84.6) | 1.3 (0.56–2.86) | 0.57 |
| No | 48 | 39 (81.3) | ||
| Gastrointestinal signs | ||||
| Yes | 45 | 37 (82.2) | 0.9 (0.37–1.99) | 0.61 |
| No | 225 | 189 (84.0) | ||
| Muscular Pain | ||||
| Yes | 151 | 129 (85.4) | 1.6 (0.80–3.12) | 0.10 |
| No | 85 | 66 (77.6) | ||
| NA | 34 | - | ||
| Headache | ||||
| Yes | 156 | 132 (84.6) | 1.4 (0.70–2.86) | 0.18 |
| No | 78 | 62 (79.5) | ||
| NA | 35 | - |
*denotes statistical analysis was performed by Chi-squared test, and for other variables logistic regression test (single variable analysis) was used